Valvular heart disease: novel transcatheter approaches

Session comprising selected EuroPCR 2023 Innovation submissions

Anchorperson: J. Hausleiter
Spokesperson: P. Buszman
SHOW MORE

Summary

Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.

Presentations available when logged in:

  • First-in-man experience with the CroíValve DUO tricuspid coaptation valve system
  • Initial experiences of a vertical spacer for reduction of tricuspid regurgitation
  • Preliminary experimental experiences with novel TTVR to treat severe tricuspid regurgitation
  • Early outcomes of a cross-caval device in high-risk tricuspid regurgitation
  • GEMINI - Calcium modifying treatment for stenotic aortic valves
  • Commissural alignment with balloon expandable aortic valve: OctaAlign technique
  • A new TMVR system